![Lannett Company, Inc. [LCI] Price Analysis: NYSE:LCI Bull Target $11.50 or Higher](https://globalresearchsyndicate.com/wp-content/uploads/2019/12/wn3iop4-j3a.jpg)
The share price of Agios Pharmaceuticals, Inc. [NASDAQ: AGIO] inclined by $40.94, presently trading at $42.58. The company’s shares saw 50.16% gains compared to the lowest price in the period of the last 52 weeks, set at $28.36 recorded on Dec 9, 2019. The last few days have been benevolent to the share price as AGIO jumped by +10.59% during the last week, even though the stock is still down by -9.72% compared to 4.10 of all time high it touched on 12/09/19. However, the stock had a strong performance during the past 3 months, roughly gaining 21.20%, while additionally dropping -27.14% during the last 12 months. Agios Pharmaceuticals, Inc. is said to have a 12-month price target set at $64.18. That means that the stock has a strong potential to acquire 21.6% increase from the current trading price.
Agios Pharmaceuticals, Inc. [NASDAQ:AGIO]: Analyst Rating and Earnings
Its stock price has been found in the range of 28.36 to 68.94. This is compared to its latest closing price of $40.94.
Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on Thu 13 Feb (In 66 Days).
Fundamental Analysis of Agios Pharmaceuticals, Inc. [AGIO]
Now let’s turn to look at profitability: with a current Operating Margin for Agios Pharmaceuticals, Inc. [AGIO] sitting at -384.03 and its Gross Margin at +90.92.
What about valuation? This company’s Enterprise Value to EBITDA is -6.09. The
Enterprise Value to Sales for this firm is now 19.23. Agios Pharmaceuticals, Inc. [AGIO] has a Price to Book Ratio of 3.90.
Shifting the focus to workforce efficiency, Agios Pharmaceuticals, Inc. [AGIO] earns $195,824 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 13.22 and its Total Asset Turnover is 0.13. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 6.55 and its Current Ratio is 6.56. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Agios Pharmaceuticals, Inc. [AGIO] has 65.72M shares outstanding, amounting to a total market cap of $2.69B. Its stock price has been found in the range of 28.36 to 68.94. At its current price, it has moved down by -38.23% from its 52-week high, and it has moved up 50.16% from its 52-week low.
This stock’s Beta value is currently 2.28, which indicates that it is 3.37% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 77.69. This RSI suggests that Agios Pharmaceuticals, Inc. is currently Overbought.
Conclusion: Is Agios Pharmaceuticals, Inc. [AGIO] a Reliable Buy?
Shares of Agios Pharmaceuticals, Inc. [AGIO], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.
